Indications and uses
to prevent and relieve nasal symptoms of hay fever and other nasal allergies: • runny/itchy nose • sneezing • allergic stuffy nose
to prevent and relieve nasal symptoms of hay fever and other nasal allergies: • runny/itchy nose • sneezing • allergic stuffy nose
• see package insert on how to use pump • parent or care provider must supervise the use of this product by young children • adults and children 2 years and older: • spray once into each nostril. Repeat 3-4 times a day (every 4-6 hours). If needed, may be used up to 6 times a day. • use every day while in contact with the cause of your allergies (pollen, molds, pets, and dust) • to prevent nasal allergy symptoms, ...
(Adults and children 2 years and older)
Drug Facts
Cromolyn sodium 5.2 mg
Nasal allergy symptom controller
to prevent and relieve nasal symptoms of hay fever and other nasal allergies:
If pregnant or breast feeding, ask a health professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
benzalkonium chloride, edetate disodium, purified water
Serious side effects associated with use of this product may be reported to: 1-800-323-0000
Before using any medication read all label directions. Keep carton and packaging insert. They contain important information.
Cromolyn Sodium Nasal Solution is convenient and easy to administer using the metered spray pump. See package insert for spray pump directions.
USE ONLY IF BODY SEAL IMPRINTED WITH "Protective Seal" AND YELLOW IS INTACT.
Distributed by:
MAJOR PHARMACEUTICALS
31778 Enterprise Drive,
Livonia, MI 48150 USA
Re-Order No. 248634
©Major Pharmaceuticals
M-115 Rev 10-10

MAJOR®
NDC 0904-5532-67
Cromolyn Sodium Nasal
Solution USP
NASAL SPRAY
Nasal Allergy Symptom Controller
Prevents and Relieves
Nasal Allergy Symptoms:
runny/itchy nose
sneezing
allergic stuffy nose
Without Drowsiness
Full Prescription Strength
Safe For Ages 2 Years & Older
200 Metered Sprays
Each spray delivers 5.2 mg cromolyn sodium
0.88 FL OZ (26 mL)
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-5532-67 | ML - Milliliter | 0904-5532 | 6b5ba6fe-ec71-4991-88a2-7b523a088725 | 1 | 2012-07-24 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CROMOLYN SODIUM | ACTIVE INGREDIENT | Q2WXR1I0PK | 4 | |
| CROMOLYN | ACTIVE MOIETY | Y0TK0FS77W | 4 | |
| BENZALKONIUM CHLORIDE | INACTIVE INGREDIENT | F5UM2KM3W7 | 4 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 4 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0904-5532 | 0904-5532-67 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CROMOLYN SODIUM | Q2WXR1I0PK | ACTIB |
| BENZALKONIUM CHLORIDE | F5UM2KM3W7 | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| WATER | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RECTAL | 97 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAVENOUS | 7 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION, EXTENDED RELEASE / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET / ORAL | 100 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / OPHTHALMIC | 0.05 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SOFT TISSUE | 0.05 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | OINTMENT / TOPICAL | 0.03 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SPRAY, METERED / NASAL | 4 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / ORAL | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SYRUP / ORAL | 40 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ELIXIR / ORAL | 1.3 mg/5ml | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION / OPHTHALMIC | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EFFERVESCENT / ORAL | 32 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / INTRAMUSCULAR | 4 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAMUSCULAR | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION/ DROPS / OPHTHALMIC | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CAPSULE / ORAL | 5 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / TOPICAL | 0.05 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVASCULAR | 0.48 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | INJECTION / INTRAMUSCULAR | 1 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SHAMPOO / TOPICAL | 0.2 %w/w | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY / NASAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRALESIONAL | 0.05 %w/v | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.02 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / OPHTHALMIC | 0.3 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | ENEMA / RECTAL | 60 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / NASAL | 100 mg/100ml | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | LIQUID / NASAL | 0.2 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / AURICULAR (OTIC) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | DROPS / NASAL | 0.1 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CONCENTRATE / ORAL | 20 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / ORAL | 30 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SOLUTION / RESPIRATORY (INHALATION) | 0.02 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO, SUSPENSION / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 19 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, EXTENDED RELEASE / ORAL | 10 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SUSPENSION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRAVENOUS | 10 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | CLOTH / TOPICAL | NA | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LOTION / TOPICAL | 22 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION / SUBCUTANEOUS | 6 mg | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | GEL / OPHTHALMIC | 0.01 %w/w | ||
| BENZALKONIUM CHLORIDE | BENZALKONIUM CHLORIDE | F5UM2KM3W7 | SPRAY, METERED / NASAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION / RESPIRATORY (INHALATION) | 0.01 %w/v | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / NASAL | 2 mg/1ml | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / ORAL | 0.5 mg/1ml |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075702-001 | CROMOLYN SODIUM | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A075702-001 | CROMOLYN SODIUM | 5.2MG/SPRAY | SPRAY, METERED / NASAL | RS | 2001-07-03 | 3a93d1ddd44b… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 1ce95420-cc85-495c-81b2-c1cc60e79d5b | fcdf672f-9114-4246-9e06-5622b233759e | 2013-09-03 | Warnings | fcdf672f-9114-4246-9e06-5622b233759e |
Adverse event summaries are temporarily unavailable. Other product information remains available.